Avadel Pharmaceuticals PLC reports results for the quarter ended September 30 - Earnings Summary

Avadel Pharmaceuticals

12/11/2024 15:39

* Avadel Pharmaceuticals PLC  AVDL.OQ  reported a quarterly
adjusted loss of 3 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -41 cents.  The mean expectation of
ten analysts for the quarter was for a loss of 6 cents per
share. Wall Street expected results to range from -11 cents
to -1 cents per share.
    * Revenue rose 613.2% to $50.03 million from a year ago;
analysts
expected $48.61 million. 
    * Avadel Pharmaceuticals PLC's reported EPS for the quarter
was a
loss of 3 cents​.
    * The company reported a quarterly loss of $2.63 million.
    * Avadel Pharmaceuticals PLC shares had risen by 24.3% this
quarter and gained 15.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Avadel
Pharmaceuticals PLC is 24.00 
This summary was machine generated from LSEG data November 12 at
03:39 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.06          -0.03          Beat
 Jun. 30 2024      -0.16          -0.14          Beat
 Mar. 31 2024      -0.21          -0.30          Missed
 Dec. 31 2023      -0.26          -0.29          Missed